Doppler Ultrasonographic Assessment of Fetal Internal Thoracic Artery Indexes
NCT ID: NCT04686240
Last Updated: 2020-12-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2021-01-31
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In literature, there are so many articles that have been focused on thymus size in pregnancies complicated with diabetes mellitus, fetal growth restriction, preterm rupture of membranes and so on. To the best of our knowledge, there is no paper about fetal ITA whose branch are feeding vessel of thymus and ITA Doppler velocity. The arteries supplying the thymus are branches of the internal thoracic, and inferior thyroid arteries. As far as it has been known, growing of a tissue depends on increased blood flow. Before detecting possible blood-flow changes in fetuses complicated with great obstetrics patologies, the investigators should obtain normal values of ITA Doppler velocity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having no fetal anomalies
* healthy pregnant women age \>17 and \<45 years
* between 24th-32nd gestational weeks
Exclusion Criteria
* underlying chronic diseases
* pregnant women complicated with gestational diabetes, Type 1-2 DM, hypertension (pregnancy-induced; chronic; preeclampsia), malignancy
* pregnancy complicated with preterm premature rupture of membranes, preterm labour, fetal growth restriction and another obstetric complication
17 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Betül Yakıştıran
specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
betül yakıştıran, MD
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospital Bilkent
aykan yücel, professor
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospital Bilkent
mihriban alkan, MD
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospital Bilkent
seval erdinç, assoc prof
Role: PRINCIPAL_INVESTIGATOR
ankara city hospitalBilkent
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
internalthoracicarterydoppler
Identifier Type: -
Identifier Source: org_study_id